Obstructive Uropathy Treatment Market

Obstructive Uropathy Treatment Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment; 2018 - 2028

  • Ongoing
  • June 2020
  • REP-GB-8324
  • PDF PPT EXCEL
Obstructive Uropathy Treatment Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Obstructive Uropathy Treatment market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Obstructive Uropathy Treatment market.


Obstructive uropathy is interference and hindrance in the urinal tract causing barriers for the normal flow of urine completely or partially. Obstructive uropathy can be a result of structural or functional malfunction blocking the drainage of urine and can cause serious complications if not treated. Obstructive uropathy can be a chronic or acute disease. Obstructive uropathy treatment is applicable to people of all age groups as it may occur to individual of any age. Obstructive uropathy registers for 10% of the causes of acute renal failure and 4% of the cases of chronic end stage renal failure. Obstructive uropathy can be caused due to neoplastic, inflammation or may be inherited. Obstructive uropathy treatment involves introduction of catheters or stents in kidney or ureter to restore the normal flow of urine. Obstructive uropathy treatment is performed by minimal invasion and has significantly high success rate.  Nephro-ureterostomy catheter passes through the skin and allows the flow of urine from bladder to the renal pelvis. Ureteral stent is implanted in the ureter and acts as tube to allow flow of urine from kidney to bladder. Hydronephrosis is the condition in which there is excess fluid present in the kidney which is cured by obstructive uropathy treatment. Prompt relief of obstruction by obstructive uropathy treatment market usually leads to preservation of kidney function.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Obstructive Uropathy Treatment Market: Drivers and Restraints

The increasing prevalence of kidney stone due to changing lifestyle is the key factor propelling the expansion of global obstructive uropathy treatment market. Furthermore, increasing incidence of cancer and post-operative infection in kidney transplant patients fuel the expansion of obstructive uropathy treatment market. The rising prevalence of hydronephrosis in the population is also expected to create a high demand for obstructive uropathy treatment over the forecast period. The rising number of manufacturers and distributors of catheters and stents for obstructive uropathy treatment are increasing the regional availability of the products in untapped regions and fueling the expansion of the obstructive uropathy treatment market. The increasing progress in research and development and improvement in patient outcomes is expected to create further opportunities in the obstructive uropathy treatment market over the forecast period.

Obstructive Uropathy Treatment Market: Overview

The global obstructive uropathy treatment market is expected to witness significant growth over the forecast period owing to the increasing adoption of the products by the end users. From an autopsy series of 59,064 subjects ranging in age from infants to geriatric people, it was reported that 3.1% were positive for hydronephrosis and this number is further anticipated to rise propelling demand for obstructive uropathy market. On the basis of product type, the ureteral stent segment is projected to register maximum market share in the terms of revenue over the forecast period owing to the better patient outcomes and availability of specific product types according to the requirements in the obstructive uropathy treatment market. The ambulatory surgical centers' segment in end users is expected to grow with the fastest CAGR in the obstructive uropathy treatment market owing to the increasing number of outpatient centers.

Obstructive Uropathy Treatment Market: Regional Wise Outlook

Geographically, global obstructive uropathy treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the leader in global obstructive uropathy treatment market owing to the high prevalence of urological disorders in the region and higher expenditure of healthcare. Europe obstructive uropathy treatment market is projected to account for the second largest share in the obstructive uropathy treatment market over the forecast period due to higher spending on healthcare and greater adoption by the end users in the region. Asia-Pacific excluding Japan market for obstructive uropathy treatment is expected to grow with fast CAGR over the forecast period owing to the rising presence of manufacturers and increasing adoption by the end users. MEA obstructive uropathy treatment market is expected to witness below average growth due to lack of awareness and limited players in the region.

Obstructive Uropathy Treatment Market: Key Players

Some of the major players identified in the global obstructive uropathy treatment market are Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, B. Braun Melsungen AG, Applied Medical, AngioDynamics, Merit Medical Systems, Inc., Argon Medical Devices, Inc., optimed, Cook Medical, and C. R. Bard amongst others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Obstructive Uropathy Treatment Market Segments
  • Obstructive Uropathy Treatment Market Dynamics
  • Obstructive Uropathy Treatment Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Obstructive Uropathy Treatment Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Obstructive Uropathy Treatment Market: Segmentation

Tentatively, the global obstructive uropathy treatment Market has been segmented on the basis of product type, end user, and geography.

Based on product type, global obstructive uropathy treatment market is divided into following:

  • Nephro-ureterostomy catheter
  • Ureteral Stents
  • Open end stents
  • Closed end stents
  • Double pigtail stents
  • Multi-loop stents

Based on end users, global obstructive uropathy treatment market is divided into following:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Obstructive Uropathy Treatment Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Obstructive Uropathy Treatment Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology